Practical parameters of hyposensitization;Praktische Durchführung der Hyposensibilisierung

Monatsschrift fur Kinderheilkunde

Volumn 161, Issue 7, 2013, Pages 608-615

  Fischer, P J ^a   Friedrichs, F ^b  

^a Praxis für Kinder und Jugendmedizin ^*  (Germany)

^b Kinderarztpraxis Laurensberg   (Germany)

Author keywords

Allergen immunotherapy; Hyposensitization; Practice parameters; Subcutaneous injections; Sublingual administration

Indexed keywords

ALLERGEN;

ADOLESCENCE; ALLERGIC DISEASE; ALLERGIC REACTION; ARTICLE; CHILD HEALTH CARE; CLINICAL PRACTICE; DESENSITIZATION; EMERGENCY CARE; EMERGENCY TREATMENT; EQUIPMENT; IMMUNOTHERAPY; LONG TERM CARE; SHORT COURSE THERAPY; TREATMENT INDICATION;

EID: 84880239205     PISSN: 00269298     EISSN: 14330474     Source Type: Journal    
DOI: 10.1007/s00112-012-2803-5     Document Type: Article

References (26)

1. Abramson MJ, Puy RM, Weiner JM (2010) Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 8:CD001186
2. Alvarez-Cuesta E, Bousquet J, Canonica GW et al (2006) Standards for practical allergen-specific immunotherapy. Allergy [Suppl 82] 61:1-20
3. Arzneimittelkommission der Deutschen Ärzteschaft (2007) Stellungnahme der AkdÄ zur allergen-spezifischen Immuntherapie. Dtsch Arztebl 104:A-3355
4. Aschermann U, Schulte P, Hecker H (2010) Untersuchungen zur Compliance eines anwenderfreundlichen Allergoids. Allergo J 19(S1):63
5. Bousquet J, Lockey R, Malling HJ (1998) Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102:558-562
6. Cox L, Nelson H, Lockey R et al (2011) Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol [Suppl 1] 127:1-55
7. Durham SR, Leung DY (2011) One hundred years of allergen immunotherapy: time to ring the changes. J Allergy Clin Immunol 127:3-7
8. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP (2006) Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 61:198-201
9. Englert L, May S, Kaul S et al (2012) Therapieallergene-Verordnung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55:351-357
10. Frew AJ, Powell RJ, Corrigan CJ et al (2006) Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117:319-325
11. Friedrichs F, Niggemann B (2008) Hyposensibilisierung im Kindes- und Jugendalter: 100 Fragen - 100 Antworten. Wurms, Tutzing, S 66
12. Frost L, Johansen P, Petersen S et al (1985) Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts. Allergy 40:368-372
13. Jacobsen L, Niggemann B, Dreborg S et al (2007) Specific immunotherapy has a long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62:943-948
14. Kleine-Tebbe J, Bufe A, Ebner C et al (2009) Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Allergo J 18:503-537
15. Kopp M, Bendiks M (2013) Spezifische Immuntherapie im Kindesalter. Subkutane oder sublinguale Applikation. Monatsschr Kinderheilkd 7 DOI 10.1007/s00112-012-2804-4
16. Lüderitz-Püchel U, Keller-Stanislawski B, Haustein D (2001) Neubewertung des Risikos von Test- und Therapieallergenen. Eine Analyse der UAW-Meldungen von 1991-2000. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 44:709-718
17. Niggemann B (2004) Die spezifische Immuntherapie im Kindesalter. Padiatr Allergol Sonderh Hyposensibilisierung 7:6-9
18. Niggemann B, Regnath T, Friedrichs F (2010) Bacteriological safety of multi-use vials for specific immunotherapy. Pediatr Allergy Immunol 21:e245-e246
19. Ohashi Y, Nakai Y, Murata K (2006) Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. Ann Allergy Asthma Immunol 96:600-605
20. Pajno GB, Barberio G, Luca F De et al (2001) Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 31:1392-1397
21. Przybilla B, Ruëff F, Walker A et al (2011) Diagnostik und Therapie der Bienen- und Wespengiftallergie (S2-Leitlinie). Allergo J 20:318-339
22. Roches A Des, Paradis L, Menardo JL et al (1997) Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99:450-453
23. Senna G, Lombardi C, Canonica GW, Passalacqua G (2010) How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. J Allergy Clin Immunol 126(3):668-669
24. Sieber J, De Geest S, Shah-Hosseini K, Mösges R (2011) Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates. Curr Med Res Opin 27(4):855-861
25. Stelmach I, Sobocińska A, Majak P et al (2012) Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy. Ann Allergy Asthma Immunol 109:274-278
26. Zuberbier T, Bachert C, Bousquet PJ et al (2010) GA2LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy 65:1525-1530